LINE-1 endonuclease inhibitors
LINE-1 endonuclease inhibitors has been studied in 1 paper since 2024: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, May 8, 2024: “Identification and characterization of small molecule inhibitors of the LINE-1 retrotransposon endonuclease”.
1 paper studies it3 findingsUpdated
See all 1 papers on LINE-1 endonuclease inhibitors
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Biological and Environmental Research and 8 more
- 3 of 3 findings with company ties
- Cells1
What did studies of LINE-1 endonuclease inhibitors find?
3Studies of LINE-1 endonuclease inhibitors measured 3 outcomes: inflammation, DNA damage response and transposable element activity.
Inflammation
downin human cells1
1 study
Inflammation
downin human cells1
LINE-1 endonuclease inhibitors decrease inflammation in senescent cells.
“We also show that these inhibitors reduce L1 retrotransposition, L1-induced DNA damage, and inflammation reinforced by L1 in senescent cells.”
Cellsin senescent cells
Nature communications
DNA damage response
downin human cells1
1 study
DNA damage response
downin human cells1
LINE-1 endonuclease inhibitors decrease DNA damage response in senescent cells.
“We also show that these inhibitors reduce L1 retrotransposition, L1-induced DNA damage, and inflammation reinforced by L1 in senescent cells.”
Cellsin senescent cells
Nature communications
Transposable element activity
downin human cells1
1 study
Transposable element activity
downin human cells1
LINE-1 endonuclease inhibitors inhibit transposable element activity in senescent cells.
“We also show that these inhibitors reduce L1 retrotransposition, L1-induced DNA damage, and inflammation reinforced by L1 in senescent cells.”
Cellsin senescent cells
Nature communications